Arch Therapeutics

0 followers


Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care.

Industries

Headquarters

Stage

Employees

Links

Terrence W. Norchi
Chairman, President & CEO

Terrence W. Norchi

Collapse
Richard E. Davis
Chief Financial Officer
Chirag B. Shah
VP of R&D Engineering & Quality Systems
Evelyn Quintin
Senior Medical Science Liaison
Shawn Carlson
Vice President Of Sales